INTRODUCTION
p53 is an important component of pathways mediating cellular response to genotoxic stress by inducing the transcription of a variety of genes that regulate diverse cellular processes including cell-cycle progression, apoptosis, and genomic stability (Harris and Levine, 2005; Vogelstein et al., 2000; Vousden and Lu, 2002) . However, little is known about the mechanism (or mechanisms) that determines which sets of target genes-i.e., cell-cycle arrest genes like p21 (El-Deiry et al., 1993) and 14-3-3s (Hermeking et al., 1997) or proapoptotic genes such as Bax (Miyashita and Reed, 1995) , Noxa (Oda et al., 2000; Villunger et al., 2003) , Pidd (Lin et al., 2000) , Puma (Nakano and Vousden, 2001; Villunger et al., 2003) , Perp (Attardi et al., 2000) , etc.-are transactivated by p53 under a specific condition. In order to perform its cellular functions, p53 must rapidly accumulate in response to stressful conditions, as its basal level is very low. Activation of p53 has two major outcomes: cell-cycle arrest or apoptosis. Cellcycle arrest allows DNA repair to take place before replication occurs, thereby maintaining genomic integrity. On the other hand, apoptosis results in elimination of irreparably damaged cells.
The regulation of p53 is usually achieved by posttranslational modifications and through its interactions with various other proteins (Lavin and Gueven, 2006) . p53 undergoes phosphorylations on numerous serine residues in both N-and C-terminal regions (Lavin and Gueven, 2006) . The N-terminal phosphorylations inhibit its interactions with its negative regulator Mdm2 (Canman et al., 1998; Chehab et al., 2000; Khosravi et al., 1999) , while the C-terminal phosphorylations are thought to enhance its sequence-specific DNA-binding ability by inducing a conformational change (Hupp et al., 1992; Wang and Prives, 1995) . Similarly, other modifications like ubiquitination, acetylation, and sumoylation also affect its proteolytic turnover and sequence-specific DNA-binding ability (Brooks and Gu, 2006; Rodriguez et al., 1999) . This can also be achieved by its interaction with cellular proteins such as Pin-1, ASPP family members, etc. (Braithwaite et al., 2006) . When Pin-1 binds to p53, it undergoes a conformational change that enhances its transactivation ability (Zacchi et al., 2002; Zheng et al., 2002) . Recently, the ASPPs have been found to be potent activators of p53, providing an important insight into how p53 responds to apoptotic signals (Trigiante and Lu, 2006) . The ASPP family consists of three members: ASPP1, ASPP2, and iASPP. ASPP1 and ASPP2 interact with p53 and specifically enhance p53-induced apoptosis but not cell-cycle arrest, while iASPP binds p53 and inhibits p53-mediated apoptosis (Bergamaschi et al., 2006; Samuels-Lev et al., 2001) .
While studying the genome-wide transcriptional response to p53 induction, we found that one of the genes upregulated was the hematopoietic zinc finger (Hzf) gene. Hzf was originally identified as a gene induced in hematopoietic progenitor cells following differentiation of murine embryonic stem cells (Hidaka et al., 2000) . Hzf encodes a zinc-finger protein of 366 amino acids with three C 2 H 2 -type zinc-finger domains. The zinc-finger domains in Hzf are widely spaced with long linker regions connecting the fingers, as a consequence of which it cannot form any stable nucleic acid-protein complexes (Sharma et al., 2004) . Recently, it was reported that Hzf is a direct transcriptional target of p53 that plays a role in p53-mediated cell-cycle arrest in response to DNA damage in NIH 3T3 cells (Sugimoto et al., 2006) . We found that Hzf is unique among the different p53 transcriptional targets in that, upon induction by p53 or DNA damage, it binds to the p53 DNA-binding domain and modulates its transactivation function in an autoregulatory feedback loop. We further investigated the role of Hzf in the p53-mediated DNA damage response. Here, we show that when Hzf binds to p53, it is preferentially recruited to the promoters of its pro-cell-cycle-arrest target genes rather than to its proapoptotic target genes. Thus, in the presence of Hzf, p53-mediated cell-cycle arrest is promoted while apoptosis is repressed in response to genotoxic stress.
RESULTS

Inhibition of Hzf Induction in Response to DNA Damage Represses p21 Expression but Enhances Bax Levels
Through microarray analysis of cDNA expression, we previously identified Hzf as one of the upregulated genes whose transcript levels are elevated in response to p53 induction (Han et al., 2002) . To confirm the array result, we carried out several northern and western blot analyses to examine Hzf expression in response to different types of stresses in several cell lines of diverse tissue origin and different p53 background. Under various stress conditions including DNA damage and oxidative stress, Hzf was induced in a p53-dependent manner ( Figure 1A) . Moreover, promoter analysis including the reporter gene assay and chromatin immunoprecipitation (ChIP) analysis supported the conclusion that Hzf is a direct p53 transcriptional target (see Figure S1 in the Supplemental Data available with this article online).
To investigate the role of Hzf in p53-mediated stress response, we examined whether Hzf induction contributes directly to the ability of p53 to transactivate p21 and Bax. To do so, we used short hairpin RNA (shRNA) against Hzf to knock down the induction of endogenous Hzf in response to p53-dependent DNA damage response or ectopic p53 expression. We transiently transfected U2OS (wild-type [WT] p53) and EJ (nonfunctional p53) cell lines with Hzf shRNA or scrambled shRNA constructs followed by treatment with the chemotherapeutic agent etoposide or infection with Ad-p53 to induce p53 expression ( Figure 1B) . Transfection of Hzf shRNA resulted in the suppression of endogenous Hzf induction by etoposide treatment or Ad-p53 infection, while control scrambled shRNA had no effect on induced Hzf levels. In U2OS cells transfected with the scrambled shRNA construct, upon etoposide treatment or Ad-p53 infection, concomitant with p53 induction, Hzf and p21 induction was seen while Bax levels were minimally increased. However, depletion of Hzf expression resulted in enhanced Bax induction while p21 induction was significantly reduced in response to DNA damage ( Figure 1B, left panel) . In EJ cells containing nonfunctional p53, similar results were obtained with Ad-p53 infection ( Figure 1B, right panel) . To exclude offtarget effects of shRNA, two other Hzf shRNAs were used, and similar results were obtained (data not shown).
We next examined the levels of p21 and Bax transcripts in response to DNA damage (via etoposide treatment) in Hzf +/+ and Hzf À/À MEFs. As shown in Figure 1C , Hzf
MEFs showed drastically lower induction levels of p21 mRNA than Hzf +/+ MEFs, while Bax induction was significantly enhanced in Hzf À/À MEFs. To further investigate the role of Hzf in p53-mediated transcription of these target genes, we used reporter assays with either the p21 or Bax promoter fused to a luciferase reporter (pGL3-basic, pGL3-p21-Luc, and pGL3-Bax-Luc). U2OS and EJ cells were cotransfected with Hzf shRNA or scrambled shRNA constructs together with pGL3-basic, pGL3-p21-Luc, or pGL3-Bax-Luc constructs followed by treatment with etoposide or infection with Ad-p53 ( Figure 1D ). We found that the ability of p53 to transactivate the p21 promoter was severely compromised upon knockdown of Hzf, while its ability to transactivate the Bax promoter was significantly enhanced in response to etoposide treatment or Ad-p53 infection in U2OS cells containing WT p53 ( Figure 1D , upper panel). In the EJ cells, this effect was also observed upon ectopic p53 expression ( Figure 1D , lower panel). All of these results suggested that Hzf affects p53-mediated transcription in a positive manner for p21 transcription and in a negative manner for Bax transcription.
Hzf Is Induced by p53 and Binds Directly to Its DNA-Binding Domain Because Hzf is a zinc-finger protein (Hidaka et al., 2000) that is induced by p53 and modulates p53-mediated transactivation, we next tested whether Hzf physically interacts with p53. For this purpose, we utilized extracts made from U2OS cells treated with etoposide or EJ cells infected with Ad-p53 for immunoprecipitation using the p53-specific monoclonal antibody PAb1801. In both cell lines, we found that Hzf coimmunoprecipitated with p53 ( Figure 2A , top panels). We also performed a reverse coimmunoprecipitation experiment in which immunoprecipitation was carried out using anti-Hzf polyclonal antibody. As shown in Figure 2A (bottom panels), p53 also coimmunoprecipitated with Hzf. As a control, an immunoprecipitation was carried out in etoposide-treated Hzf À/À MEFs using Hzf antibody. As shown in Figure S2 , p53 did not appear in the precipitated complex, and no Hzf was detected, confirming the specificity of the Hzf antibody used.
To determine whether the interaction between Hzf and p53 is a direct one, a yeast two-hybrid assay was performed. Expression constructs in which p53 was fused to the Gal4 DNA-binding domain (pGBKT7-p53) and Hzf was fused to the Gal4 transactivation domain (pGADT7-Hzf) were generated and then transformed into yeast strains AH109 and Y187, respectively. Blue-colored Ade + /His + colonies were obtained when yeast transformants containing pGBKT7-p53 and pGADT7-Hzf were mated, as observed in a positive control mating experiment between p53 (pGBKT7-p53) and SV40 T antigen (pGADT7-T Ag) ( Figure 2B ) (Iwabuchi et al., 1993; Li and Fields, 1993) .
To map the domain of p53 to which Hzf binds, we carried out GST pull-down experiments in which constructs expressing different domains of p53 fused to GST were transfected into EJ cells followed by infection with control Ad-GFP or Ad-Hzf. As shown in Figure 2C , Hzf bound to GST-p53 (full length) but not to GST alone, supporting our immunoprecipitation and yeast two-hybrid results. The GST-p53 segment containing aa 100-300 specifically bound to the Hzf protein, which represents the DNA-binding domain of p53 ( Figure 2C ). To study the Hzf-p53 interaction more closely, we determined whether Hzf could bind to tumor-derived p53 DNA-binding domain mutants including p53/175Pro, p53/175His, and p53/143Ala. It was previously reported that p53/175His and p53/ 143Ala have no DNA-binding ability while p53/175Pro is capable of some DNA-binding activity but can trigger only arrest and not apoptosis (Kern et al., 1991; Rowan et al., 1996; Zhang et al., 1994) . As shown in Figure 2D , Hzf bound to WT p53 robustly, but reduced binding was observed with p53/175Pro and p53/175His, and the binding of Hzf with p53/143Ala was severely repressed. Nevertheless, none of these p53 mutations was able to abolish the Hzf-p53 interaction completely. This suggests that p53-Hzf interaction involves several key residues in the DNA-binding domain of p53 and that mutation in any one of them weakens the binding but cannot fully abolish it. Together, these results indicate that Hzf is induced by p53 and directly binds to its DNA-binding domain.
Hzf Influences the Specificity of p53-Mediated Transactivation
Since our results demonstrated that Hzf binds to p53 and differentially modulates expression levels of the p53 targets p21 and Bax, we next determined whether this regulation of p53 transactivation function by Hzf is a wideranging phenomenon encompassing other proarrest and proapoptotic p53 targets. To this end, we infected Hzf
and Hzf À/À MEFs with adenovirus expressing p53 (Adp53) or treated the cells with etoposide and analyzed the expression of p53 target genes including both proarrest and proapoptotic targets. In the presence of Hzf, ectopic (A) U2OS and EJ cells were treated with ETO (40 mM) or infected with Ad-p53, respectively, for 24 hr. The cells were then harvested and subjected to immunoprecipitations using anti-p53 antibody (top panels) or anti-Hzf antibody (bottom panels), and western blots were performed for the indicated proteins.
(B) Yeast two-hybrid assay to show direct interaction between Hzf and p53 was carried out as described in Experimental Procedures.
(C) The region of p53 involved in binding to Hzf was analyzed in GST pull-down assays. U2OS cells were transfected with the indicated GST-p53 plasmids and then infected with Ad-GFP or Ad-Hzf. Twenty-four hours postinfection, the cells were lysed and subjected to GST pull-down. Western blotting was then performed for p53 and FLAG epitope.
(D) Mutations in the DNA-binding domain of p53 affect the Hzf-p53 interaction. EJ cells containing nonfunctional p53 were transfected with the indicated p53 plasmids and then infected with Ad-GFP or Ad-Hzf. Twenty-four hours postinfection, the cells were lysed and subjected to immunoprecipitations using anti-p53 antibody. Western blotting was then performed for p53 and FLAG epitope.
p53 or etoposide treatment preferentially induced expression of the proarrest p53 targets p21 and 14-3-3s, whereas in the absence of Hzf, the expression of the proapoptotic targets Bax, Perp, Puma, and Noxa was selectively induced ( Figures 3A and 3B ). Induced levels of Mdm2, a p53 target involved in p53 protein regulation that does not specifically influence either arrest or apoptosis, were not affected by Hzf inactivation (Figures 3A and  3B ). In addition, exogenous expression of Hzf in Hzf
MEFs restored preferential induction of the cell-cycle arrest targets p21 and 14-3-3s and lowered the levels of Perp, Puma, Noxa, and Bax expression without any concomitant change in p53 induction of Mdm2 ( Figure 3C ). To further evaluate the effect of Hzf on the transactivation function of p53, we measured DNA-binding activity of p53 in response to DNA damage on the promoters of p53 targets including p21, Bax, Noxa, Perp and Hzf À/À MEFs were exposed to etoposide for 24 hr, and ChIP assays were performed using control IgG or p53 antibody for several p53 target genes. Upon DNA damage treatment of Hzf +/+ MEFs, p53 predominantly bound to the promoters of proarrest targets such as p21 and 14-3-3s, but DNA-binding activity of p53 on the promoters of proapoptotic target genes such as Bax, Perp, and Noxa was significantly lower ( Figure 3D ). In contrast, in Hzf null MEFs, upon DNA damage, the DNA-binding activity of p53 to the promoters of various proapoptotic target genes, including Bax, Perp, and Noxa, was significantly enhanced as compared to that of p21 and 14-3-3s ( Figure 3D ). p53's ability to bind to the Mdm2 and Hzf promoters remained unchanged irrespective of Hzf status. Quantitative ChIP assays by real-time PCR also confirmed the above results with WT and Hzf À/À MEFs ( Figure S3 ). These results strongly suggest that, upon Hzf binding to p53, p53 is preferentially recruited to the promoters of its cell-cycle-arrest-mediating target genes. To further verify this, we performed ''re-ChIP'' experiments using Hzf antibody. As shown in Figure 3E , Hzf was detected at the promoters of p21, 14-3-3s, Hzf, and Mdm2, but not at the promoters of Bax, Noxa, and Perp. Moreover, quantitative ChIP assays by real-time PCR were carried out with etoposide-treated p53 +/+ and p53 À/À MEFs using IgG control antibody and Hzf antibody ( Figure S4 ), the results of which indicated that Hzf is found at the cell-cycle arrest promoters only in the presence of p53. To further determine the differential effects of Hzf binding on the DNA-binding activities of p53 to its targets, an electrophoretic mobility shift assay was carried out in etoposidetreated Hzf +/+ and Hzf À/À MEFs using oligonucleotides specific for the p53 binding site in the p21 promoter (ElDeiry et al., 1993) , the Mdm2 promoter (Wu et al., 1993) , and the first intron of Bax (Thornborrow et al., 2002) . As shown in Figure 3F , the DNA-binding activity of p53 on the p21 promoter was significantly increased in etoposide-treated WT MEFs, whereas there was no strong DNA-binding activity of p53 on the first intron of Bax. In the absence of Hzf, no significant binding activity of p53 was observed on the p21 promoter, but significantly higher DNA-binding activities were seen on the first intron of Bax ( Figure 3G ). The binding of p53 to the Mdm2 promoter remained unchanged irrespective of Hzf status. Taken together, these data demonstrate that Hzf preferentially enhances the DNA-binding and transactivation functions of p53 on cell-cycle arrest targets such as p21 and 14-3-3s.
Hzf Promotes the Cell-Cycle Arrest Function of p53
We next examined the effects of Hzf on p53-mediated cell-cycle arrest and apoptosis in Hzf +/+ and Hzf
MEFs. In Hzf +/+ MEFs, the ectopic expression of p53 by
Ad-p53 infection induced prominent G1 arrest but little apoptosis (Figure 4 ). In Hzf À/À MEFs, the apoptotic function of p53 was significantly enhanced, as measured by TUNEL assay, sub-G1 population, and DNA fragmentation ( Figures 4A and 4B ). To further verify whether Hzf deficiency indeed modulates p53 functions under physiological conditions, Hzf +/+ and Hzf À/À MEFs were exposed to etoposide, and TUNEL-positive apoptotic cells were then measured. The loss of Hzf led to enhanced apoptosis sensitivity to etoposide ( Figure 4C , left panel). Re-expression of Hzf in Hzf À/À MEFs through Ad-Hzf infection reversed this effect of Hzf deficiency and resulted in a decrease in apoptosis induced by etoposide treatment or overexpression of p53, similar to that seen in etoposide-treated or Ad-p53 infected Hzf +/+ MEFs ( Figure 4C ). This was due to altered DNA-binding activity of p53 ( Figure S5 ). These results indicate that Hzf modulates the p53-mediated stress response favoring cell-cycle arrest over apoptosis.
Prolonged p53 Expression/Activation or Extended Exposure to Stress Results in Hzf Protein Degradation Leading to Apoptosis
To examine whether levels of Hzf expression are correlated with levels of genotoxic stress, we investigated the kinetics of Hzf induction over extended periods during stress response in U2OS cells. The results shown in Figure 5A suggest that Hzf protein expression is induced within 36 hr in response to etoposide treatment or ectopic p53 expression; however, beyond 36 hr, Hzf protein levels start declining and are markedly decreased at 72 hr. p21 expression also followed a pattern similar to that observed with Hzf. In contrast, Bax protein levels rose very slowly up to 36 hr but exhibited a sharp increase beyond that time ( Figure 5A ).
We also immunoprecipitated p53 over the time course of etoposide treatment to examine the amount of Hzf bound to p53. We found that there was a sharp decline in the amount of p53-bound Hzf beyond the 36 hr time point to undetectable levels by 72 hr ( Figure 5B ). However, Hzf mRNA levels remained steady throughout the time course while mRNA levels of p21 and Bax were similar to their protein levels ( Figure 5C ), suggesting that Hzf downregulation is due to the degradation of the Hzf protein. To determine the implications of these differential responses in Hzf protein levels in response to genotoxic stress or ectopic p53 induction, we next tested the cellcycle profile under these conditions by flow cytometry. Ad-p53 overexpression induced a pronounced arrest in the G1 phase of the cell cycle at 24-36 hr ( Figure 5D ), after which there was a marked increase in the apoptotic population. TUNEL staining confirmed these results (Figure 5E ). These results indicate that extended exposure to stress and the induction of a p53-mediated apoptotic response are correlated with a reduction of Hzf, suggesting that Hzf may play a role in controlling the switch in the p53-dependent stress response.
Since the ubiquitin-mediated proteasome degradation pathway is a frequently engaged mechanism for protein downregulation, we investigated the potential role of the proteasome in stress-induced Hzf protein degradation in cells undergoing p53-dependent apoptotic response. We treated U2OS cells with etoposide for 0, 36, and 72 hr. At 10 hr prior to the end of the 72 hr period, the cells were treated with the proteasome inhibitor MG132. Loss of Hzf triggered by genotoxic stress at the 72 hr time point was significantly attenuated by MG132, resulting in elevated p21 levels ( Figure 5F ). However, Bax levels were diminished at 72 hr in the MG132-treated U2OS cells similarly to those at 36 hr ( Figure 5F ). Furthermore, proteasome inhibitor treatment elevated the levels of p21 mRNA but decreased Bax mRNA ( Figure 5G ), supporting the hypothesis that the preferential DNA-binding activities of p53 to the p21 promoter result from stabilization of Hzf protein. This was confirmed by ChIP as well as quantitative ChIP assays by real-time PCR ( Figure 5H ; Figure S6A ). We next determined whether prolonged stress in cells triggers the polyubiquitination of Hzf prior to Hzf degradation. Treatment of U2OS cells with etoposide in the presence of MG132 revealed that endogenous Hzf undergoes extensive ubiquitination after prolonged exposure (72 hr) to genotoxic stress, while no such ubiquitinated forms were observed at 36 hr of treatment ( Figure 5I ). Moreover, MG132-mediated stabilization of Hzf indeed prevented the p53-mediated apoptosis upon prolonged exposure to genotoxic stress ( Figures S6B and S6C) . Thus, the appearance of ubiquitinated forms of Hzf in cells treated with MG132 supports the idea that the Hzf protein is targeted for degradation following prolonged exposure to genotoxic stress due to activation of a ubiquitinationproteasome pathway resulting in initiation of the apoptotic process.
Hzf À/À Mice Exhibit Increased Sensitivity to g Irradiation While mice lacking Hzf seemed to be relatively phenotypically normal, initial characterization suggested a role for Hzf in megakaryopoiesis and hemostasis (Kimura et al., 2002) . To further study the role of Hzf in genotoxic stress response in vivo, we investigated the functional consequences of Hzf deficiency in Hzf null mice exposed to g irradiation. Hzf À/À mice and WT littermates (14 weeks old) were exposed to 5 Gy total-body g irradiation. 6.5 hr after treatment, three mice from each group were evaluated by examining sensitivity to cell death using TUNEL staining and histopathological analysis of target organs including skin, spleen, small intestine, and prostate. As shown in Figures 6A and 6B , skin and prostate from irradiated Hzf À/À mice showed increased sensitivity to DNA damage induced by g irradiation as measured by TUNEL staining. However, the extent of apoptosis in WT prostate was less than that in skin and was associated with increased expression of Hzf in prostate as compared to skin ( Figure 6C ). TUNEL staining and immunostaining for Hzf was also carried out in ionizing radiation (IR)-sensitive tissues like spleen and small intestinal epithelium, where we found extensive apoptosis and low levels of Hzf expression upon g irradiation ( Figure S7 ). In spleen, no difference was observed in the levels of apoptosis between Hzf +/+ and Hzf À/À samples in response to IR; in contrast, in the small intestine, we observed slightly higher levels of apoptosis in Hzf À/À samples. Thus, our results demonstrate an inverse correlation between sensitivity to g irradiation and levels of Hzf expression. We also performed immunostaining for the p53 targets p21 and Bax in the same sections of skin and prostate from WT and Hzf À/À mice. In response to g irradiation, the level of Bax expression was increased in Hzf À/À skin compared to skin from WT mice, while p21 levels were reduced in g-irradiated Hzf À/À skin samples ( Figure 7A ).
Similar results were obtained in prostate tissue from irradiated Hzf À/À mice ( Figure 7B ). In concurrence with TUNEL staining, Bax staining in Hzf À/À prostate was also less pronounced as compared to skin, while the pattern of p21 staining was reversed. These results support a role for
Hzf downstream of p53 in the p53-dependent DNA damage response, acting as a critical switch that prevents apoptosis by repressing transactivation of proapoptotic p53 targets both in vitro and in vivo. Thus, the results from the mouse model suggest that, under in vivo conditions, Hzf modulates the p53-mediated stress response but that there is an element of tissue specificity in this regulation due to varying degrees of Hzf expression in different tissues upon g irradiation.
DISCUSSION
It is widely accepted that the p53 tumor suppressor restricts the proliferation of cells exposed to genotoxic stress by inducing growth arrest or by triggering cell death (Vousden and Lu, 2002) . This process depends mainly on the expression of genes that regulate cell-cycle arrest and/or apoptosis. A critical unresolved issue about the DNA damage response is how the resulting upregulation of the p53 tumor suppressor can lead either to cell-cycle arrest and DNA repair or to apoptosis. Here we present evidence that Hzf plays a critical role in p53-mediated transcription and functions as a key player in controlling a cellular regulatory switch that dictates the cellular decision toward cell-cycle arrest in response to stress. The existence of an autoregulatory feedback loop involving p53 and its target proteins such as Mdm2, Pirh2, and Cop1 is well established (Dornan et al., 2004; Leng et al., 2003; Wu et al., 1993) . These proteins are known to have ubiquitin ligase activity and can target p53 for ubiquitination and degradation to maintain low basal levels of the p53 protein. Unlike these p53 target proteins, Hzf is a zinc-finger domain protein, and its binding to p53 does not seem to regulate p53 stability in response to stress. Instead, induction of Hzf and its binding to p53 selectively influence the specificity of p53-mediated transcription, resulting in preferential transactivation of downstream cellcycle arrest target genes such as p21 and 14-3-3s. It has been previously shown that Hzf is a direct p53 transcriptional target in NIH 3T3 cells (Sugimoto et al., 2006) . Promoter analyses revealed that p53 could bind directly to the p53-responsive element in the first intron of the Hzf gene. Moreover, Hzf was found to have a role in cell-cycle checkpoint control, specifically at the G2/M checkpoint. Strikingly, knockdown of Hzf expression promoted p21 ubiquitination and degradation, the mechanism of which was not elucidated. We independently identified Hzf as a p53 target gene in human cells, and our promoter analysis strongly suggests that, unlike mouse Hzf, the p53-responsive element in human Hzf is located at the À1044 base pair of the promoter region ( Figure S1 ). Our results show further that Hzf binds to p53, resulting in preferential transactivation of proarrest p53 target genes. Thus, upon genotoxic stress, abrogation of Hzf expression results in preferential transactivation of proapoptotic p53 target genes such as Bax, Perp, Puma, and Noxa over its proarrest targets such as p21 and 14-3-3s. Hence, our results argue that downregulation of p21 and other proarrest p53 targets in the absence of Hzf is transcriptional in nature.
Our results also indicate that the level of Hzf protein is inversely correlated with the extent of genotoxic stress. Prolonged p53 activation/expression or extended exposure to stress induced Hzf protein degradation through activation of a ubiquitination-proteasome pathway whose consequences are induction of proapoptotic p53 targets such as Bax, Puma, Noxa, and Perp. Thus, we propose a model ( Figure 7C ) wherein p53 activates Hzf, which then binds to p53 in an autoregulatory feedback loop. Hzf-bound p53 is specifically recruited to cell-cycle arrest gene promoters, resulting in growth arrest. Prolonged p53 expression is associated with Hzf degradation, which then allows p53 activation of proapoptotic targets, resulting in apoptosis. However, if cells lack the mechanism for Hzf degradation, prolonged p53 expression leads to senescence, and shRNA-mediated inhibition of Hzf expression makes the cells highly apoptotic ( Figure S8 ). Therefore, our results provide a novel mechanism for modulation of Figure 6A .
(B) Immunostaining for p21 and Bax proteins in prostate tissue from the same IR-treated Hzf À/À mice and wild-type littermates as in Figure 6B .
(C) Model for p53-dependent cell fate control through the p53/Hzf/p53/Hzf autoregulatory feedback loop. p53 activation by DNA damage induces Hzf, which binds to p53. This directs p53 preferentially to cell-cycle arrest gene promoters, resulting in growth arrest. Upon extended or irreparable stress, Hzf ubiquitination/degradation prevents this from occurring, thus allowing p53 to activate proapoptotic targets and resulting in apoptosis. The ubiquitin ligase and the proteins that facilitate the interaction between Hzf and the ubiquitin ligase are currently unknown. a p53-dependent DNA damage response. It will be of interest to determine the expression pattern of p53-regulated genes by microarray analysis in the absence or presence of Hzf as well as the specific interacting partner (or partners) that mediates Hzf ubiquitination/degradation. Recently, it was shown that Tip60-dependent acetylation of p53 at lysine 120 modulates the decision between cellcycle arrest and apoptosis, leading to enhanced p53-dependent apoptotic response (Sykes et al., 2006; Tang et al., 2006) . Thus, it will be interesting to determine whether the acetylation of K120 within the DNA-binding domain of p53 affects Hzf-mediated preferential transactivation of proarrest p53 target genes. While the role of Mdm2 in p53 regulation is well established, we found that there is no role for Mdm2 in Hzf degradation ( Figure S9 ). Another question remains as to whether cells that have a deficiency of one or more proarrest or proapoptotic p53 targets can affect the Hzf-mediated cell fate decision upon genotoxic stress. In HCT116 and HCT116 p21 À/À cells, genotoxic stress results in cell-cycle arrest in both cell lines, with p21 À/À cells showing a higher extent of G2/M arrest. When Hzf is also knocked down under such conditions, both cell lines show much-increased apoptosis levels with marginal differences between them ( Figure S10 ). Thus, Hzf likely plays a key role in sustaining p53-mediated cell-cycle arrest through other proarrest p53 target genes such as 14-3-3s in addition to p21. It is well established that HCT116 Bax À/À cells are resistant to apoptosis upon DNA damage (Zhang et al., 2000) . When Hzf was depleted in parental HCT116 and HCT116 Bax À/À cells, there was a significant induction of apoptosis in both cell types following DNA damage; however, the extent of apoptosis was higher in wild-type cells (data not shown). Thus, Hzf appears to influence cell fate following genotoxic stress through modulation of p53-mediated transactivation of multiple proarrest and proapoptotic genes.
Targeted Hzf disruption in the mouse germline has no reported effects on cell-cycle dynamics, but general growth retardation and internal hemorrhaging in the brains of Hzf À/À mice have been observed (Kimura et al., 2002) . While mice lacking Hzf seemed to be otherwise normal, the initial characterization of Hzf null mice suggested a role for Hzf in megakaryopoiesis and hemostasis. Based on our in vitro characterization of the role of Hzf in p53-dependent stress response, we carried out an analysis of Hzf function in response to irradiation under in vivo conditions using Hzf knockout mice. We observed that exposure to IR results in increased cell death in Hzf À/À mice as compared to wild-type littermates, especially in the epidermis and prostate epithelium. However, comparison of the extent of apoptosis between the different tissues of g-irradiated Hzf À/À mice revealed significant differences, indicative of some tissue specificity with respect to Hzf function due to varying degree of Hzf expression in different tissues upon g irradiation. While our preliminary investigations reveal some evidence for epithelial hyperplasia in organs like lung, mammary gland, etc. of Hzf À/À mice, further studies will be needed to elucidate the role of Hzf in tumor susceptibility in mice and its implications for human cancer. The findings presented here establish that Hzf functions downstream of p53 in the DNA damage response and acts as a critical switch favoring cell-cycle arrest over apoptosis. Hzf appears to govern this key event by promoting preferential transactivation of proarrest p53 targets both in vitro and in vivo. Thus, Hzf is both a p53 target and an important modulator of p53 functions, adding a new layer of complexity to the mechanisms by which p53 determines cell fate decisions in response to cellular stresses.
EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions U2OS, LNCaP, Saos2, HCT116, HCT116 p53 À/À (Bunz et al., 1998) , Waldman et al., 1996) , and HCT116 Bax À/À (Zhang et al., 2000) cells were cultured in DMEM containing fetal bovine serum (FBS) (Invitrogen), 100 U/ml penicillin, and 100 mg/ml streptomycin at 37 C. Hzf +/+ and Hzf À/À early-passage MEFs (Kimura et al., 2002) were also maintained in DMEM containing 10% FBS. For drug treatment, cells were grown to $50% confluency prior to exposure to the DNA-damaging agents for the indicated time. Adenoviruses expressing Hzf or GFP were generated, amplified, and titrated as previously reported (Ongusaha et al., 2003) . Cells were grown to $50%-70% confluency and infected with recombinant adenovirus at a multiplicity of infection of 10-20 for the indicated time. GFP-expressing adenovirus (Ad-GFP) was used as a control.
GST Pull-down Assay and Yeast Two-Hybrid Assay Cells were lysed in lysis buffer (20 mM Tris-HCl [pH 7.4], 5 mM EDTA, 10 mM Na 4 P 2 O 7 , 100 mM NaF, 2 mM Na 3 VO 4 , 1% NP-40, 1 mM phenylmethylsulfonyl fluoride [PMSF] , 13 protease inhibitor cocktail [Roche] ). Five hundred microgram cell extracts pretreated with MNase as described (Groisman et al., 2003) were subjected to GST pull-down following the manufacturer's protocol (Amersham). Yeast two-hybrid assay was performed following the manufacturer's protocol (Clontech). Briefly, Hzf cloned in the pGADT7 vector was transformed into yeast strain Y187, mated with yeast strain AH109 carrying the pGBKT7-p53 plasmid, and then plated on SD/ÀTrp/ÀLeu and SD/ ÀTrp/ÀLeu/ÀAde/ÀHis plates. Representative colonies for the positive control, negative controls, and the test interaction were then streaked onto a SD/ÀTrp/ÀLeu/ÀAde/ÀHis/X-a-Gal plate.
Apoptosis and Flow Cytometry
Apoptosis was detected using the Cell Death Detection ELISA kit (Roche) and TUNEL assay (Roche). For Cell Death Detection ELISA, cells were lysed, and the amount of nucleosomes in the cytoplasmic fraction of the cell lysates was measured using anti-histone antibody and anti-DNA antibody linked to peroxidase in a sandwich ELISAbased protocol. For calculating relative nucleosome content, the absorbance of all of the samples was normalized with respect to that of untreated/untransfected cells. Error bars are means ± SD of three independent experiments with triplicate samples. For TUNEL assay, cells were fixed with paraformaldehyde, stained by TUNEL reaction using TMR red-conjugated nucleotides, and counterstained with DAPI. For each sample, five random fields were counted, and error bars are means ± SD of three such independent experiments. Cellcycle analysis using flow cytometry was carried out as described previously (Han et al., 2002) .
shRNA Vectors expressing shRNA against Hzf (5 0 -ATCCGCTTCAATTCTCA GA-3 0 ) and the scrambled sequence (5 0 -GAGCCCTATTTCACAACTT-3 0 ) were generated using the pBabe-U6-shRNA plasmid. Cells were transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.
Total-Body Irradiation and Immunohistochemistry
Fourteen-week-old Hzf À/À mice and age-and sex-matched wild-type littermates were subject to 5 Gy of total-body irradiation with a 137 Cs g source at a rate of 0.6 Gy/min. All animal protocols were approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee. 6.5 hr later, the animals were euthanized. Tissues were harvested, fixed in formalin, washed with PBS, and embedded in paraffin for sectioning. Immunohistochemical analyses of the tissues were carried out by fluorescence microscopy. Briefly, 5 mm paraffin sections were dewaxed and immunostained with Bax (Santa Cruz) or p21 (Calbiochem) antibody followed by counterstaining with TO-PRO-3 (Invitrogen). TUNEL staining of dewaxed sections was carried out as described above.
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